Orthopedic Devices are used to treat the disorders and injuries of the musculoskeletal system of human body. Digits Replacement is a surgical intervention mainly performed to treat arthritis of the digits of the hand during which one or more damaged joint surfaces in the digits are replaced by artificial implants. GlobalData uses proprietary data and analytics to provide a comprehensive report on the digits replacement market in New Zealand. Buy the latest report here.
Smarter leaders trust GlobalData
In 2023, GlobalData’s Market Model methodology determined that the leading player in the digits replacement market in New Zealand was Smith & Nephew followed by Depuy Synthes, Stryker and KLS Martin.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Digits Replacement covers devices (implants) used for primary replacements. Hand Digits Implants are used to replace the diseased or damaged Metacarpophalangeal (MP) and Proximal Interphalangeal (PIP) joints of the hand.
The digits replacement market in New Zealand can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size digits replacement in New Zealand, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
